Researchers have used a urine test to identify and verify a patient's type of asthma, laying the foundation for a more personalised diagnosis and improved treatment.
Bruker's B.I.QUANT-UR 1.1 module automatically quantifies up to 150 endogenous and disease-related metabolites from urine, allowing users to obtain precise, sensitive and fully reproducible results, even below the limit of detection (LOD).
PhenoMeNal is an online portal that allows researchers and clinicians to analyse large metabolomics datasets.
A newly developed medical device pairs a handheld sensor with a smartphone app and measures the levels of various metabolites in fluid samples from patients.
Life sciences company Thermo Fisher Scientific and research centre SRI International have announced a collaboration to enhance small molecule research.
Bruker has announced a product for the quantification of metabolites in urine using nuclear magnetic resonance (NMR). The B.I.QUANT-UR module of the company's Avance IVDr (In Vitro Diagnostics research) NMR platform is designed to provide precise, sensitive and fully reproducible results that have demonstrated potential in preclinical animal and clinical/translational research.
US researchers have identified a characteristic chemical signature that they believe will improve diagnosis of chronic fatigue syndrome and provide clinical targets for personalised care.
Good performance and versatility, combined with user-friendly software, make the ABCA2 from Sercon a suitable choice for 13C breath tests for helicobacter pylori detection. Enabling high throughput, the product is based on isotope ratio mass spectrometry (IRMS) and provides 0.1% precision.
Researchers have shown in a mouse model that infection with roundworms (nematodes) can not only combat obesity but ameliorate related metabolic disorders.
Through the national network for metabolite analysis and identification, Metabolomics Australia, Murdoch University’s Separation Science and Metabolomics Laboratory recently received $1 million for infrastructure and equipment.
A new diagnostic test that uses a scientific technique known as metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection.
United Bioresearch has available the complete range of Abraxis ELISA assays and test kits for real-time testing for endocrine disrupting chemicals, estrogens, antibiotics, pesticides, industrial chemicals, surfactants, marine biotoxins, cyanotoxins, mycotoxins, residues, additives and vitellogenin.
The Roche Cedex Bio Bioprocess Analyzer is a continuous random-access analyser, enabling a safe and reliable determination of chemical and biochemical parameters in aqueous solutions. The compact desktop system is designed to fulfil the essential needs for metabolite screening and substrate analysis of bioprocesses.
Enzo Life Sciences colorimetric ELISA kits for the quantitative determination of intracellular or extracellular cAMP or cGMP in cell lysates, culture supernatants, serum, saliva and tissue from any species are claimed to be the most sensitive and complete colorimetric ELISA kits.
The Seahorse Extracellular Flux (XF) Analyzer makes cellular bioenergetic studies simple, efficient and user friendly. The in vitro metabolic measurement systems non-invasively profile the metabolic activity of cells in minutes, offering a physiologic cell-based assay for determination of basal oxygen consumption, glycolysis rates, ATP turnover and respiratory capacity in a single experiment to assess mitochondrial dysfunction.